Nutrition, gUT Microbiota, and BRain AgINg: the NutBrain Study
NCT04461951 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 643
Last updated 2020-07-08
Summary
Epidemiological evidence suggests that healthy diet is associated with a slowdown of cognitive decline leading to dementia, but the underlying mechanisms are still partially unexplored. Diet is the main determinant of gut microbiota' composition, which in turn impacts on brain structures and functions, however to date no studies on this topic are available. The goal of the present paper is to describe the design and methodology of the NutBrain Study aimed at investigating the association of dietary habits with cognitive function, and their role in modulating the gut microbiota composition, and brain measures as well.
This is a population-based cohort study of community-dwelling adults aged 65 years or more living in Northern Milan, Italy. At the point of presentation people are screened for cognitive functions. Socio-demographic characteristics along with lifestyles and dietary habits, medical history, drugs, functional status, and anthropometric measurements are also recorded. Individuals suspected to have cognitive impairment at the screening phase undergo a clinical evaluation including a neurological examination and a Magnetic Resonance Imaging (MRI) scanning (both structural and functional). Stool and blood samples for the gut microbiota analysis and for the evaluation of putative biological markers are also collected. For each subject with a confirmed diagnosis of Mild Cognitive Impairment (MCI), two cognitively intact controls of the same sex and age are visited. The investigators intend to enrol at least 683 individuals for the screening phase and approximately 240 persons for the clinical assessment.
The NutBrain is an innovative study that incorporates modern and advanced technologies (i.e. microbiome and neuroimaging) into traditional epidemiologic design. The study represents a unique opportunity to address key questions about the role of modifiable risk factors on cognitive impairment, with a particular focus on dietary habits and their association with gut microbiota and markers of the brain-aging process. These findings will help to encourage and plan lifestyle interventions, for both prevention and treatment, aiming at promoting healthy cognitive ageing.
Conditions
- Cognitive Dysfunction
- Dietary Habits
Interventions
- OTHER
-
Lifestyles (exposure)
no intervention
Sponsors & Collaborators
-
Institute of Biomedical Technologies-National Research Council (ITB-CNR)
collaborator UNKNOWN -
IRCCS National Neurological Institute "C. Mondino" Foundation
lead OTHER
Principal Investigators
-
Federica Prinelli, PhD · IRCCS C. Mondino Foundation
Eligibility
- Min Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2019-04-01
- Primary Completion
- 2021-10-31
- Completion
- 2022-04-30
Countries
- Italy
Study Locations
More Related Trials
-
Polyamine-enriched Diet in Elderly Individuals With Subjective Cognitive Decline
NCT03094546 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of a Colon-delivered Multivitamin Supplement on Brain Functioning, Immunometabolic- and Intestinal Markers in Ageing
NCT05675007 ·Status: COMPLETED ·Phase: NA
-
The Memory and Cognitive Performance Study
NCT04025255 ·Status: COMPLETED ·Phase: NA
-
Dementias and Microbiota Composition: Is Possible to Revert the Dementia Symptoms Reverting the Microbiota Composition?
NCT05943925 ·Status: UNKNOWN
-
BRain Energy Activation With Ketones to Prevent Alzheimer's Disease
NCT04466735 ·Status: COMPLETED ·Phase: NA
-
Cytokines and Cognitive Decline in Alzheimer's Disease
NCT01351142 ·Status: COMPLETED ·Phase: NA
-
Effects of a Food Supplement on Cognitive and Neuropsychological Functioning in Older Adults.
NCT03145987 ·Status: COMPLETED ·Phase: NA
-
The Influence of Vascular Burden, Amyloid Plaque and Tau Protein in Patients With Vascular Cognitive Impairment and Dementia With Tauopathy
NCT04309253 ·Status: RECRUITING ·Phase: PHASE2
-
Effect of BrainPhyt, a Microalgae Based Ingredient on Cognitive Function in Healthy Older Subjects
NCT04832412 ·Status: COMPLETED ·Phase: NA
-
INSIDE: Intervention in Nutritional Supplementation to Improve Cognitive Decline in Elderly.
NCT07000500 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Effects of Mitochondrial-targeted Antioxidant on Mild Cognitive Impairment (MCI) Patients
NCT03514875 ·Status: WITHDRAWN ·Phase: NA
-
Influence of Oxidative Stress and Nutrition Biomarkers on the Cognitive Decline Evolution in Alzheimer Disease
NCT02800395 ·Status: RECRUITING ·Phase: NA
-
Clinical and Genetic Study of Neurodegenerative Disorders With Cognitive Impairment
NCT00149175 ·Status: COMPLETED
-
Effectiveness of A Nutritional Brain Metabolic Enhancer for Alzheimer Disease
NCT00013923 ·Status: COMPLETED ·Phase: PHASE2
-
A Noval Tau Tracer in Young Onset Dementia
NCT04248270 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Evaluation of the Effects of a Nutritional Intervention of Ketogenic Medium-chain Triglycerides and B-vitamins on Cognitive Functioning in Older Adults With Mild Cognitive Impairment (COGNIKET-MCI)
NCT06347315 ·Status: RECRUITING ·Phase: NA
-
Gut Microbiota and Alzheimer's Diseases
NCT03827733 ·Status: UNKNOWN
-
A Medium Chain Triglyceride Intervention for Patients With Alzheimer Disease
NCT02912936 ·Status: COMPLETED ·Phase: NA
-
Non-pharmacological Intervention for Preclinical Alzheimer's Disease
NCT04279418 ·Status: COMPLETED ·Phase: NA
-
Brain Imaging and Mental Disorders of Aging Intervention
NCT00267163 ·Status: COMPLETED ·Phase: PHASE4
-
Effects of a Nutraceutic Compound on Cognitive Impairment
NCT06200883 ·Status: COMPLETED ·Phase: PHASE4
-
Phosphatidylserine Improves Cognitive Function in the Elderly
NCT04920305 ·Status: UNKNOWN ·Phase: NA
-
Motor Slowing and Its Lesion-related Correlates in Alzheimer's Disease
NCT02811653 ·Status: UNKNOWN ·Phase: NA
-
Correlation of P-glycoprotein Polymorphisms With Microbial Metabolites in Patients With Alzheimer's Disease on Medication
NCT05532644 ·Status: UNKNOWN
-
Lifestyle Intervention Program for Cognitive Impairment
NCT02741804 ·Status: UNKNOWN ·Phase: NA